Stocks
Merck KGaA ADR Beats Expectations with Strong Q2 Earnings
Merck KGaA ADR's latest earnings call was marked by an upbeat tone, with management highlighting accelerating organic growth and widening margins across key business segments.
The company reported a 3.4% year-over-year increase in net sales to EUR 5.434 billion in Q2 2026, driven mainly by strong demand in Life Science and a sharp rebound in Electronics.
EBITDA pre increased by 9.4% to EUR 1.6 billion, with the group's EBITDA pre margin expanding by 1.6 percentage points to 29.4%, underscoring effective cost discipline and mix improvements.